• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1992 Fiscal Year Final Research Report Summary

Study on the physiological and pathological significances of lipoprotein(a).

Research Project

Project/Area Number 02454498
Research Category

Grant-in-Aid for General Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field Laboratory medicine
Research InstitutionGifu University

Principal Investigator

NOMA Akio  School of Medicine Professor, 医学部, 教授 (30208384)

Co-Investigator(Kenkyū-buntansha) OKUNO Masataka  University Hospital Assistant, 医学部附属病院, 助手 (10204140)
SEISHIMA Mitsuru  School of Medicine Assistant, 医学部, 助手 (10171315)
ABE Akira  University Hospital Lecturer, 医学部附属病院, 講師 (30175898)
SHIMOKAWA Kuniyasu  School of Medicine Assistant Professor, 医学部, 助教授 (70021376)
Project Period (FY) 1990 – 1992
KeywordsLipoprotein(a) / Lp(a) phenotype / Coronary artery disease / Acute phase reactant / Interleukin-6 / Coagulation / Fibrinolysis / Plasminogen
Research Abstract

1) Lp(a) assay method and normal value in Japan. We evaluated the ELISA kit for Lp(a) determination, and the immunological interference by plasminogen on the assay. Results obtained by this assay method were compared with those by our polyclonal ELISA method. Serum Lp(a) was determined in 1513 healthy Japanese with use of the assay method.
2) Lp(a) phenotype frequencies in healthy Japanese and in patients with CAD. The distribution of Lp(a) levels, mean and median values, and Lp(a) phenotype and allele frequencies in healthy Japanese were not significantly different from the results for Europeans, whereas they were significantly different from other Asian populations. The frequencies of Lp(a) alleles in the CAD patients were not significantly different from those in the healthy subjects. Lp(a) levels in the patients were higher than those in the healthy subjects with the same phenotype.
3) Change as an acute phase reactant. Although IL-6, CRP and alpha_1-antitrypsin reached the maximal levels 1-2 days, 3 days and 4-5 days after the episodes, respectively, the peak time of Lp(a) levels delayed some extent in myocardial infarction and surgical operated groups. Studying on the transient increases of Lp(a) levels as a function of apo(a) isoforms, the higher density Lp(a) particles preferentially containing high molecular weight apo(a) isoforms were more increased than the lower density Lp(a) particles.
4) Relationship between Lp(a) and clinical parameters in the hemostatic process. Plasma concentrations of Lp(a), TAT, t-PA, PAI-1, t-PA-PAI-1 complex and PIC were determined in healthy subjects and in patients with CAD. Lp(a) levels showed a significant positive correlation with PIC values in the healthy group, whereas this correlation was disappeared in the CAD group. These results suggest that Lp(a) has the potential to regulate the coagulation-fibrinolytic system and that it may interfere with the fibrinolytic system in patients with CAD.

  • Research Products

    (13 results)

All Other

All Publications (13 results)

  • [Publications] 安部 彰 他: "ELISAキット法によるLp(a)リポ蛋白の測定とプラスミノーゲンとの免疫交差性について" 臨床病理. 38. 722-727 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] A.Noma et al: "Reduction of serum lipoprotein(a) levels in hyperlipidemic patients with α-tocopheryl nicotinate." Atherosclerosis. 84. 213-217 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] K.Makino et al: "Lipoprotein(a):Nonhuman primate models." Lipids. 26. 679-683 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 矢野 容子 他: "Lipoprotein(a)と線溶系パラメーターとの関連" 動脈硬化. 20. 645-649 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] A.Abe et al: "Studies on apolipoprotein(a) phenotypes.Part 1.Phenotype frdquencies in a healthy Japanese population." Atherosclerosis. 96. 1-8 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] A.Abe et al: "Part 2.Phenotype frequencies and Lp(a) concentrations in different phenotypes in patients with CHD." Atherosclerosis. 96. 9-15 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 野間 昭夫 他 (分担): "ビタミンE研究の進歩II" 共立出版KK, 206 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 野間 昭夫 (分担): "メディコピア「高脂血症をめぐって」" 富士レビオKK, 285 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] A.Noma et al: "Reduction of serum lipoprotein(a) levels in hyperlipidemic patients with alpha-tocopherol nicotinate." Atherosclerosis. 84. 213-217 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] K.Makino et al.: "Lipoprotein(a): Nonhuman primate models." Lipids. 26. 679-683 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] K.Makino et al.: "Attenuation of immunologic, reactivity of lipoprotein(a) by thiols and cysteine-containing compounds. Structural implications." Arteriosclerosis & Thrombosis. 12. 424-429 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] A.Abe et al.: "Studies on apolipoprotein(a) phenotypes. Part 1. Phenotype frequencies in a healthy Japanese population." Atherosclerosis. 96. 1-8 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] A.Abe et al.: "Studies on apolipoprotein(a) phenotypes. Part 2. Phenotype frequencies and Lp(a) concentrations in different phenotypes in patients with angiographically defined coronary artery disease." Atherosclerosis. 96. 9-15 (1992)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1994-03-24  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi